| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |